Publication Title: 
Journal of Affective Disorders

BACKGROUND: In 2001, the Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical guidelines for the treatment of depressive disorders. A revision of these guidelines was undertaken by CANMAT in 2008-2009 to reflect advances in the field. There is widespread interest in complementary and alternative medicine (CAM) therapies in the treatment of major depressive disorder (MDD). METHODS: The CANMAT guidelines are based on a question-answer format to enhance accessibility to clinicians.

Ravindran, Arun V.
Lam, Raymond W.
Filteau, Marie J.
Lespérance, François
Kennedy, Sidney H.
Parikh, Sagar V.
Patten, Scott B.
Canadian Network for Mood and Anxiety Treatments (CANMAT)
Publication Title: 
Climacteric: The Journal of the International Menopause Society

A number of health and lifestyle factors are thought to contribute to cognitive decline associated with age but cannot be easily modified by the individual patient. We identified 12 individually modifiable interventions that can be implemented during midlife or later with the potential to ameliorate cognitive aging. For ten of these, we used PubMed databases for a systematic review of long-duration (at least 6 months), randomized, controlled trials in midlife and older adults without dementia or mild cognitive impairment with objective measures of neuropsychological performance.

Lehert, P.
Villaseca, P.
Hogervorst, E.
Maki, P. M.
Henderson, V. W.
Publication Title: 

2-Deoxy-D-glucose (2-DG) and dehydroepiandrosterone (DHEA) have been hypothesized to extend lifespan via mimicking calorie restriction (CR). Activation of sirtuins has been proposed to contribute to life extension of CR by increasing intercellular levels of NAD(+) in several organisms. However, it is unclear whether 2-DG and DHEA may affect intracellular NAD(+) levels and human sirtuin 1 (SIRT1) activities. Here, using human fibroblast Hs68 cells we showed that 2-DG increased intracellular NAD(+) levels in both time- and concentration-dependent manners.

Yang, Nae-Cherng
Song, Tuzz-Ying
Chen, Mei-Yau
Hu, Miao-Lin
Publication Title: 
The New England Journal of Medicine
Schneider, E. L.
Reed, J. D.
Publication Title: 
Journal of the American Geriatrics Society

Dietary caloric restriction is the most robust and reproducible means of slowing aging and extending lifespan and healthspan in short-lived mammals and lower organisms. Numerous aspects of this paradigm have been investigated in laboratories around the world since its inception more than 60 years ago. However, two questions about calorie restriction remain unanswered to this day: (1) By what mechanism does it work? and (2) Will it work in humans?

Roth, G. S.
Ingram, D. K.
Lane, M. A.
Publication Title: 
Mayo Clinic Proceedings

Nothing has been demonstrated to slow or reverse the primary aging process in humans; instead, the factors that are known to affect longevity do so by their influence on disease development, which is part of secondary aging. Preventive strategies against secondary aging are aimed at maintaining health and functional capacity and rectangularizing, rather than extending, the survival curve. Interventions for preventive geriatrics and successful aging include a low-fat, low-energy diet with a high content of fruits and vegetables; exercise; and hormone replacement.

Holloszy, J. O.
Publication Title: 
Frontiers in Neuroendocrinology

DHEA and DHEAS are steroids synthesized in human adrenals, but their function is unclear. In addition to adrenal synthesis, evidence also indicates that DHEA and DHEAS are synthesized in the brain, further suggesting a role of these hormones in brain function and development. Despite intensifying research into the biology of DHEA and DHEAS, many questions concerning their mechanisms of action and their potential involvement in neuropsychiatric illnesses remain unanswered.

Maninger, Nicole
Wolkowitz, Owen M.
Reus, Victor I.
Epel, Elissa S.
Mellon, Synthia H.
Publication Title: 
The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry

Stress is commonly associated with a variety of psychiatric conditions, including major depression, and with chronic medical conditions, including diabetes and insulin resistance. Whether stress causes these conditions is uncertain, but plausible mechanisms exist by which such effects might occur. To the extent stress-induced hormonal alterations (e.g., chronically elevated cortisol levels and lowered dehydroepiandrosterone [DHEA] levels) contribute to psychiatric and medical disease states, manipulations that normalize these hormonal aberrations should prove therapeutic.

Wolkowitz, O. M.
Epel, E. S.
Reus, V. I.
Publication Title: 

Gamma-hydroxybutyrate (GHB) is a GHB-/GABAB-receptor agonist. Reports from GHB abusers indicate euphoric, prosocial, and empathogenic effects of the drug. We measured the effects of GHB on mood, prosocial behavior, social and non-social cognition and assessed potential underlying neuroendocrine mechanisms. GHB (20mg/kg) was tested in 16 healthy males, using a randomized, placebo-controlled, cross-over design. Subjective effects on mood were assessed by visual-analogue-scales and the GHB-Specific-Questionnaire.

Bosch, Oliver G.
Eisenegger, Christoph
Gertsch, J¸rg
von Rotz, Robin
Dornbierer, Dario
Gachet, M. SalomÈ
Heinrichs, Markus
Wetter, Thomas C.
Seifritz, Erich
Quednow, Boris B.
Publication Title: 
The Journal of Clinical Psychiatry

BACKGROUND: Unexplained chronic fatigue is a frequent complaint in primary care. A prospective observational study design was used to evaluate whether certain commonly used therapies for unexplained chronic fatigue may be effective. METHOD: Subjects with unexplained chronic fatigue of unknown etiology for at least 6 months were recruited from the Wisconsin Chronic Fatigue Syndrome Association, primary care clinics, and community chronic fatigue syndrome presentations. The primary outcome measure was change in a 5-question fatigue score from 6 months to 2 years.

Bentler, Suzanne E.
Hartz, Arthur J.
Kuhn, Evelyn M.


Subscribe to RSS - Dehydroepiandrosterone